Stats by Source
Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)
Total = all mutations for this gene across every source.
Cell line = COSMIC Cell Lines Project + DepMap + PubMed.
Tissue = COSMIC primary-tissue (patient tumour) samples.
Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.
| Total | Cell line | Tissue | |
|---|---|---|---|
| Mutations | 83 | 29 | 38 |
| Samples | 71 | 29 | 38 |
| Peptides | 60 | 20 | 28 |
Function
KRTAP4-16 · Keratin associated protein 4-16
Predicted to be located in keratin filament. [provided by Alliance of Genome Resources, Apr 2022]
Isoforms & Proteins
1 transcript · UniProt mapping is sequence-verified (AA-safe)
Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.
The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.
Counts are mutations and unique mutant peptides on each transcript.
| Transcript | UniProt | Mutations | Peptides |
|---|---|---|---|
| ENST00000440582 | G5E9R7 | 83 | 60 |
Gene Properties
Recurrent Mutations
All 60 amino-acid changes on canonical ENST00000440582 · needle height = samples · drag the mini-map to zoom
A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).
X-axis = amino-acid position in the protein.
Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.
The most recurrent changes are labelled; hover any needle for the change, position and counts.
Mutation frequency across cancer types
% of samples with a missense/complex mutation in KRTAP4-16 · cell line vs tissue
For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in KRTAP4-16 – counted as distinct samples (a sample counts once no matter how many mutations it has).
Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.
| Cancer type | Cell lines | Tissue samples |
|---|---|---|
| Chondrosarcoma | 1/14 7% | 0/75 0% |
| Mesothelioma | 2/62 3% | 0/165 0% |
| Gastrointestinal Stromal Tumour | 0/0 0% | 1/133 1% |
| Hodgkins Lymphoma | 1/16 6% | 0/122 0% |
| Rhabdomyosarcoma | 1/33 3% | 0/171 0% |
| Osteosarcoma | 0/45 0% | 1/166 1% |
| Hepatocellular Carcinoma | 3/46 7% | 5/2210 0% |
| Endometrial Carcinoma | 1/42 2% | 1/612 0% |
| Non-Small Cell Lung Carcinoma | 2/304 1% | 3/1390 0% |
| Biliary Tract Carcinoma | 0/54 0% | 3/950 0% |
| Melanoma | 6/210 3% | 0/1899 0% |
| Gastric Carcinoma | 0/74 0% | 5/1809 0% |
| Pancreatic Carcinoma | 2/89 2% | 2/1611 0% |
| Cervical Carcinoma | 0/35 0% | 1/422 0% |
| Colorectal Carcinoma | 4/143 3% | 3/3239 0% |
| Breast Carcinoma | 1/144 1% | 5/3264 0% |
| Thyroid Gland Carcinoma | 2/45 4% | 1/1592 0% |
| Other Blood Cancers | 0/61 0% | 4/2725 0% |
| Esophageal Squamous Cell Carcinoma | 0/51 0% | 3/2550 0% |
| Other Solid Cancers | 2/94 2% | 0/1515 0% |
| Non-Cancerous | 0/104 0% | 1/830 0% |
| Bladder Carcinoma | 0/58 0% | 1/956 0% |
| B-Cell Non-Hodgkins Lymphoma | 0/88 0% | 2/2534 0% |
| B-Lymphoblastic Leukemia | 1/55 2% | 0/2640 0% |
Mutation Distribution
Where KRTAP4-16 is mutated · all tissues, split by cell line vs tissue
How many mutations in KRTAP4-16 were found in each tissue, across the whole database.
Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.
This shows the cancer-context where this gene is recurrently altered.
Mutations
All 83 mutations in KRTAP4-16
Every mutation record for this gene, across all samples and sources.
The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).
Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.
| ID | Sample | Transcript | AA Change | CDS | Type | Source | Mutant Peptide | Wild-type Peptide |
|---|